Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery
Clinical trial NCT02959476 · COMPLETED
Trial details
- NCT number
- NCT02959476
- Sponsor
- BioQ Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2018-08-10
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.